{"filing":{"accession_number":"0001104659-26-107115","cik":"0001829635","ticker":"RNAZ","company_name":"Transcode Therapeutics, Inc.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-09","primary_document":"tm2625146d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926107115/tm2625146d1_8k.htm"},"events":[{"id":33014,"run_id":30345,"accession_number":"0001104659-26-107115","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Thomas A. Fitzgerald resigned as Chief Financial Officer, principal financial officer, principal accounting officer, and Board member effective September 9, 2026. While the filing also discloses the appointment of an interim CFO (John Tattory), the primary disclosed action centers on Fitzgerald's departure from multiple executive and board roles. The departure of a CFO and board member is material to investors assessing the registrant's financial leadership and governance.","company_name":"Transcode Therapeutics, Inc.","ticker":"RNAZ","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":36339,"accession_number":"0001104659-26-107115","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Thomas A. Fitzgerald resigned as Chief Financial Officer, principal financial officer, principal accounting officer, and Board member effective September 9, 2026. While the filing also discloses the appointment of an interim CFO (John Tattory), the primary disclosed action centers on Fitzgerald's departure from multiple executive and board roles. The departure of a CFO and board member is material to investors assessing the registrant's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T21:02:07.007716+00:00","company_name":"Transcode Therapeutics, Inc.","ticker":"RNAZ","filing_date":"2026-09-11"}]}